NRAS and acral lentiginous melanoma: The majority (47.6%) of the acral melanoma patients did not exhibit mutations in BRAF, NRAS or NF1, and a substantial portion (28.6% compared to 5.6% in BCH-cutaneous melanoma, p = 2.28e−05) presented a pigmented skin phenotype.